BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35361883)

  • 1. Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer.
    Wang C; Leavenworth J; Zhang C; Liu Z; Yuan KY; Wang Y; Zhang G; Wang S; Cui X; Zhang Y; Bae S; Zhou J; Wang L; Liu R
    Oncogene; 2022 May; 41(19):2778-2785. PubMed ID: 35361883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.
    Modelska A; Turro E; Russell R; Beaton J; Sbarrato T; Spriggs K; Miller J; Gräf S; Provenzano E; Blows F; Pharoah P; Caldas C; Le Quesne J
    Cell Death Dis; 2015 Jan; 6(1):e1603. PubMed ID: 25611378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.
    Altayyar MA; Sheng X; Wang Z
    Mol Cell Biol; 2020 Nov; 40(24):. PubMed ID: 33020149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human eukaryotic initiation factor 4AI gene (EIF4A1) contains multiple regulatory elements that direct high-level reporter gene expression in mammalian cell lines.
    Quinn CM; Wiles AP; El-Shanawany T; Catchpole I; Alnadaf T; Ford MJ; Gordon S; Greaves DR
    Genomics; 1999 Dec; 62(3):468-76. PubMed ID: 10644445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eIF4A1-dependent mRNAs employ purine-rich 5'UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation.
    Schmidt T; Dabrowska A; Waldron JA; Hodge K; Koulouras G; Gabrielsen M; Munro J; Tack DC; Harris G; McGhee E; Scott D; Carlin LM; Huang D; Le Quesne J; Zanivan S; Wilczynska A; Bushell M
    Nucleic Acids Res; 2023 Feb; 51(4):1859-1879. PubMed ID: 36727461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
    Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
    Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All trans-retinoic acid (ATRA) elevated eukaryotic translation initiation factor 4A1 (eIF4A1) mRNA in ATRA-responsive vitiliginous epidermis.
    Lee AY; Kim NH; Park SW
    Pigment Cell Res; 2004 Dec; 17(6):659-67. PubMed ID: 15541024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
    Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA helicase EIF4A1-mediated translation is essential for the GC response.
    Screen M; Matheson LS; Howden AJ; Strathdee D; Willis AE; Bushell M; Sansom O; Turner M
    Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 38011999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7.
    Miyauchi T; Takahashi M; Mitsuzuka K; Saiki Y; Okubo T; Vertino PM; Goto A; Arai Y; Horii A; Fukushige S
    Dis Markers; 2021; 2021():8858905. PubMed ID: 33628338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.
    Gao C; Guo X; Xue A; Ruan Y; Wang H; Gao X
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):310-319. PubMed ID: 32147684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
    Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
    J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.
    Chang G; Xu S; Dhir R; Chandran U; O'Keefe DS; Greenberg NM; Gingrich JR
    Clin Cancer Res; 2010 Nov; 16(22):5390-401. PubMed ID: 21062931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of the ITGB4 gene in prostate cancer.
    Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
    Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3
    Jiao D; Sun H; Zhao X; Chen Y; Lv Z; Shi Q; Li Y; Wang C; Gao K
    Elife; 2024 May; 12():. PubMed ID: 38738857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
    Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
    AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1.
    Li W; Chen A; Xiong L; Chen T; Tao F; Lu Y; He Q; Zhao L; Ou R; Xu Y
    Tumour Biol; 2017 May; 39(5):1010428317698389. PubMed ID: 28466778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.
    Wang Q; Williamson M; Bott S; Brookman-Amissah N; Freeman A; Nariculam J; Hubank MJ; Ahmed A; Masters JR
    Oncogene; 2007 Oct; 26(45):6560-5. PubMed ID: 17486081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
    Savio AJ; Bapat B
    Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.